DCF — UNIVERSITY MEDICAL CENTER
Enterprise Value: $-553.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-553.8M
Enterprise Value
$-185.2M
PV of Cash Flows
$-368.6M
PV of Terminal Value
$-593.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $645.0M | $-29.0M | -5.0% | $-56.3M | $-51.2M |
| Year 2 | $664.3M | $-23.3M | -4.0% | $-51.4M | $-42.5M |
| Year 3 | $684.3M | $-17.1M | -3.0% | $-46.1M | $-34.6M |
| Year 4 | $704.8M | $-14.1M | -2.0% | $-43.9M | $-30.0M |
| Year 5 | $725.9M | $-12.7M | -2.0% | $-43.4M | $-27.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-553.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$626.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000239543076
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5